Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
Authors:
Open Access
- 21 November 2018
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 33 (3) , e22715
Abstract
Background: Glycated hemoglobin (HbA1c) and glycated serum albumin (GSA) are used to evaluate the mean blood glucose levels. To ensure safe clinical application of HbA1c and GSA, reliable biological variation (BV) data are required. The aim of this research was to define the BV of HbA1c and GSA employing stringent rules.Methods: Blood samples were drawn from 19 healthy subjects (10 females, nine males) once per week for 5 weeks. All samples were analyzed using enzymatic method for GSA and HPLC for HbA1c. The data were assessed for outliers, normality and variance homogeneity, and coefficient of variation (by ANOVA) for BV. Sex‐stratified BV including within‐subject (CVI) and between‐subject (CVG) was defined for HbA1c and GSA.Results: The following estimates for BV values for CVI and CVG, respectively, were GSA: 1.23% and 4.67%, Alb: 0.75% and 3.18%, and HbA1c: 0.12% and 2.91%. The RCV of GSA was 3.61%, and HbA1c was 1.41%. And the II was 0.26 for GSA, and 0.07 for HbA1c, both of them less than 0.6. According to the 95% CI, the CVI of HbA1c was statistically different between females and males. And both the CVG of HbA1c and GSA were statistically different between females and males.Conclusion: All CVI and CVG estimates were lower than those reported in the online BV database. And there is a significant difference between males and females. Analytical performance specifications derived from BV of this research can be applied internationally.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2016ZR0071, 2017ZR0063)
This publication has 18 references indexed in Scilit:
- Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjectsClinical Chemistry and Laboratory Medicine (CCLM), 2018
- Harmonization initiatives in the generation, reporting and application of biological variation dataClinical Chemistry and Laboratory Medicine (CCLM), 2018
- The EuBIVAS Project: Within- and Between-Subject Biological Variation Data for Serum Creatinine Using Enzymatic and Alkaline Picrate Methods and Implications for MonitoringClinical Chemistry, 2017
- Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory MedicineClinical Chemistry and Laboratory Medicine (CCLM), 2016
- Rationale for using data on biological variationClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Biological variation – reliable data is essentialClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Biological variation database: structure and criteria used for generation and updateClinical Chemistry and Laboratory Medicine (CCLM), 2015
- Biological variation of cardiovascular risk factors in patients with diabetesDiabetic Medicine, 2013
- Prevalence and Control of Diabetes in Chinese AdultsJAMA, 2013
- Relationship between Assays of Glycemia in Diabetic Subjects with Advanced Chronic Kidney DiseaseAmerican Journal of Nephrology, 2010